DCIR maintains bone homeostasis by regulating IFN-γ production in T cells

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 5681-5691

  Maruhashi, Takumi ^a,b,c,f   Kaifu, Tomonori ^a,c,d   Yabe, Rikio ^a,c,e   Seno, Akimasa ^a,e   Chung, Soo Hyun ^a,c   Fujikado, Noriyuki ^a,d,g   Iwakura, Yoichiro ^a,b,c,d,e  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL IMMUNORECEPTOR; GAMMA INTERFERON; MEMBRANE RECEPTOR; RAG1 PROTEIN; UNCLASSIFIED DRUG; DCIR PROTEIN, MOUSE; DNA BINDING PROTEIN; LECTIN; RAG2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYLOSIS; ARTICLE; BONE MALFORMATION; BONE MASS; BONE METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMUR; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; AGE; ANIMAL; BIOSYNTHESIS; BONE; BONE DENSITY; CARTILAGE CELL; CELL DIFFERENTIATION; CYTOLOGY; DEFICIENCY; GENETICS; HOMEOSTASIS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; PATHOLOGY; RADIOGRAPHY; T LYMPHOCYTE SUBPOPULATION;

AGE FACTORS; ANIMALS; ANKYLOSIS; BONE AND BONES; BONE DENSITY; CELL DIFFERENTIATION; CHONDROCYTES; DENDRITIC CELLS; DNA-BINDING PROTEINS; HOMEOSTASIS; INTERFERON-GAMMA; LECTINS, C-TYPE; MALE; MICE; MICE, KNOCKOUT; OSTEOBLASTS; T-LYMPHOCYTE SUBSETS; X-RAY MICROTOMOGRAPHY;

EID: 84931408711     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500273     Document Type: Article

References (65)

1. Osorio, F., and C. Reis e Sousa. 2011. Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity 34: 651-664.
2. Bates, E. E., N. Fournier, E. Garcia, J. Valladeau, I. Durand, J. J. Pin, S. M. Zurawski, S. Patel, J. S. Abrams, S. Lebecque, et al. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163: 1973-1983.
3. Fujikado, N., S. Saijo, T. Yonezawa, K. Shimamori, A. Ishii, S. Sugai, H. Kotaki, K. Sudo, M. Nose, and Y. Iwakura. 2008. Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14: 176-180.
4. Kanazawa, N., T. Okazaki, H. Nishimura, K. Tashiro, K. Inaba, and Y. Miyachi. 2002. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J. Invest. Dermatol. 118: 261-266.
5. Richard, M., N. Thibault, P. Veilleux, G. Gareau-Pagé, and A. D. Beaulieu. 2006. Granulocyte macrophage-colony stimulating factor reduces the affinity of SHP-2 for the ITIM of CLECSF6 in neutrophils: a new mechanism of action for SHP-2. Mol. Immunol. 43: 1716-1721.
6. Pao, L. I., K. Badour, K. A. Siminovitch, and B. G. Neel. 2007. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu. Rev. Immunol. 25: 473-523.
7. Meyer-Wentrup, F., D. Benitez-Ribas, P. J. Tacken, C. J. Punt, C. G. Figdor, I. J. de Vries, and G. J. Adema. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 111: 4245-4253.
8. Meyer-Wentrup, F., A. Cambi, B. Joosten, M. W. Looman, I. J. de Vries, C. G. Figdor, and G. J. Adema. 2009. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J. Leukoc. Biol. 85: 518-525.
9. Raggatt, L. J., and N. C. Partridge. 2010. Cellular and molecular mechanisms of bone remodeling. J. Biol. Chem. 285: 25103-25108.
10. Takayanagi, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304.
11. Nakashima, T., M. Hayashi, T. Fukunaga, K. Kurata, M. Oh-Hora, J. Q. Feng, L. F. Bonewald, T. Kodama, A. Wutz, E. F. Wagner, et al. 2011. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17: 1231-1234.
12. Xiong, J., M. Onal, R. L. Jilka, R. S. Weinstein, S. C. Manolagas, and C. A. O'Brien. 2011. Matrix-embedded cells control osteoclast formation. Nat. Med. 17: 1235-1241.
13. Negishi-Koga, T., M. Shinohara, N. Komatsu, H. Bito, T. Kodama, R. H. Friedel, and H. Takayanagi. 2011. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 17: 1473-1480.
14. Pederson, L., M. Ruan, J. J. Westendorf, S. Khosla, and M. J. Oursler. 2008. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. Proc. Natl. Acad. Sci. USA 105: 20764-20769.
15. Tang, Y., X. Wu, W. Lei, L. Pang, C. Wan, Z. Shi, L. Zhao, T. R. Nagy, X. Peng, J. Hu, et al. 2009. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15: 757-765.
16. Zaidi, M. 2007. Skeletal remodeling in health and disease. Nat. Med. 13: 791-801.
17. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, et al. 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203: 2673-2682.
18. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
19. Azuma, Y., K. Kaji, R. Katogi, S. Takeshita, and A. Kudo. 2000. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275: 4858-4864.
20. Lee, Y. M., N. Fujikado, H. Manaka, H. Yasuda, and Y. Iwakura. 2010. IL-1 plays an important role in the bone metabolism under physiological conditions. Int. Immunol. 22: 805-816.
21. Braun, J., and J. Sieper. 2007. Ankylosing spondylitis. Lancet 369: 1379-1390.
22. Dougados, M., and D. Baeten. 2011. Spondyloarthritis. Lancet 377: 2127-2137.
23. Australo-Anglo-American Spondyloarthritis Consortium (TASC). 2010. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 42: 123-127.
24. Braun, J., M. Bollow, L. Neure, E. Seipelt, F. Seyrekbasan, H. Herbst, U. Eggens, A. Distler, and J. Sieper. 1995. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 38: 499-505.
25. Spondyloarthritis Research Consortium of Canada (SPARCC)Australo-Anglo-American Spondyloarthritis Consortium (TASC)Wellcome Trust Case Control Consortium 2 (WTCCC2). 2011. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43: 761-767.
26. Mei, Y., F. Pan, J. Gao, R. Ge, Z. Duan, Z. Zeng, F. Liao, G. Xia, S. Wang, S. Xu, et al. 2011. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin. Rheumatol. 30: 269-273.
27. Wellcome Trust Case Control ConsortiumAustralo-Anglo-American Spondylitis Consortium (TASC)Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering CommitteeBreast Cancer Susceptibility Collaboration (UK). 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39: 1329-1337.
28. Diarra, D., M. Stolina, K. Polzer, J. Zwerina, M. S. Ominsky, D. Dwyer, A. Korb, J. Smolen, M. Hoffmann, C. Scheinecker, et al. 2007. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13: 156-163.
29. Lories, R. J., I. Derese, and F. P. Luyten. 2005. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J. Clin. Invest. 115: 1571-1579.
30. Fowler, M. J., Jr., M. S. Neff, R. C. Borghaei, E. A. Pease, E. Mochan, and R. D. Thornton. 1998. Induction of bone morphogenetic protein-2 by interleukin-1 in human fibroblasts. Biochem. Biophys. Res. Commun. 248: 450-453.
31. Fukui, N., Y. Zhu, W. J. Maloney, J. Clohisy, and L. J. Sandell. 2003. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-α in normal and osteoarthritic chondrocytes. J. Bone Joint Surg. Am. 85-A(Suppl. 3): 59-66.
32. Lories, R. J., I. Derese, J. L. Ceuppens, and F. P. Luyten. 2003. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 48: 2807-2818.
33. -/- mice: role for IFN-γ in activating apoptosis of hepatocytes. J. Immunol. 159: 1418-1428.
34. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
35. Taniguchi, T., M. Takata, A. Ikeda, E. Momotani, and K. Sekikawa. 1997. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α-deficient mice. Lab. Invest. 77: 647-658.
36. Gosset, M., F. Berenbaum, S. Thirion, and C. Jacques. 2008. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3: 1253-1260.
37. Xu, Y., G. Balooch, M. Chiou, E. Bekerman, R. O. Ritchie, and M. T. Longaker. 2007. Analysis of the material properties of early chondrogenic differentiated adipose-derived stromal cells (ASC) using an in vitro three-dimensional micromass culture system. Biochem. Biophys. Res. Commun. 359: 311-316.
38. Goldring, M. B., M. Otero, K. Tsuchimochi, K. Ijiri, and Y. Li. 2008. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis. 67(Suppl. 3): iii75-iii82.
39. Ikebe, T., M. Hirata, and T. Koga. 1988. Effects of human recombinant tumor necrosis factor-alpha and interleukin 1 on the synthesis of glycosaminoglycan and DNA in cultured rat costal chondrocytes. J. Immunol. 140: 827-831.
40. Li, T. F., R. J. O'Keefe, and D. Chen. 2005. TGF-β signaling in chondrocytes. Front. Biosci. 10: 681-688.
41. Redlich, K., B. Görtz, S. Hayer, J. Zwerina, G. Kollias, G. Steiner, J. S. Smolen, and G. Schett. 2004. Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum. 50: 1001-1005.
42. Armaka, M., M. Apostolaki, P. Jacques, D. L. Kontoyiannis, D. Elewaut, and G. Kollias. 2008. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205: 331-337.
43. Crew, M. D., R. B. Effros, R. L. Walford, E. Zeller, H. Cheroutre, and E. Brahn. 1998. Transgenic mice expressing a truncated Peromyscus leucopus TNF-α gene manifest an arthritis resembling ankylosing spondylitis. J. Interferon Cytokine Res. 18: 219-225.
44. - entheseal resident T cells. Nat. Med. 18: 1069-1076.
45. Adamopoulos, I. E., M. Tessmer, C. C. Chao, S. Adda, D. Gorman, M. Petro, C. C. Chou, R. H. Pierce, W. Yao, N. E. Lane, et al. 2011. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187: 951-959.
46. Shin, H. S., R. Sarin, N. Dixit, J. Wu, E. Gershwin, E. P. Bowman, and I. E. Adamopoulos. 2015. Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J. Immunol. 194: 316-324.
47. Finnegan, A., M. J. Grusby, C. D. Kaplan, S. K. O'Neill, H. Eibel, T. Koreny, M. Czipri, K. Mikecz, and J. Zhang. 2002. IL-4 and IL-12 regulate proteoglycaninduced arthritis through Stat-dependent mechanisms. J. Immunol. 169: 3345-3352.
48. Matthys, P., R. J. Lories, B. De Klerck, H. Heremans, F. P. Luyten, and A. Billiau. 2003. Dependence on interferon-gamma for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum. 48: 2983-2988.
49. Duque, G., D. C. Huang, N. Dion, M. Macoritto, D. Rivas, W. Li, X. F. Yang, J. Li, J. Lian, F. T. Marino, et al. 2011. Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J. Bone Miner. Res. 26: 1472-1483.
50. Duque, G., D. C. Huang, M. Macoritto, D. Rivas, X. F. Yang, L. G. Ste-Marie, and R. Kremer. 2009. Autocrine regulation of interferon γ in mesenchymal stem cells plays a role in early osteoblastogenesis. Stem Cells 27: 550-558.
51. Verbruggen, G., A. M. Malfait, E. M. Veys, L. Gyselbrecht, J. Lambert, and K. F. Almqvist. 1993. Influence of interferon-γ on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. J. Rheumatol. 20: 1020-1026.
52. Gao, Y., F. Grassi, M. R. Ryan, M. Terauchi, K. Page, X. Yang, M. N. Weitzmann, and R. Pacifici. 2007. IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 117: 122-132.
53. v mutant mice. Bone 25: 261-267.
54. Takeshita, S., N. Namba, J. J. Zhao, Y. Jiang, H. K. Genant, M. J. Silva, M. D. Brodt, C. D. Helgason, J. Kalesnikoff, M. J. Rauh, et al. 2002. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyperresorptive osteoclasts. Nat. Med. 8: 943-949.
55. Abram, C. L., G. L. Roberge, L. I. Pao, B. G. Neel, and C. A. Lowell. 2013. Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity 38: 489-501.
56. Kaneko, T., Y. Saito, T. Kotani, H. Okazawa, H. Iwamura, M. Sato-Hashimoto, Y. Kanazawa, S. Takahashi, K. Hiromura, S. Kusakari, et al. 2012. Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J. Immunol. 188: 5397-5407.
57. Benjamin, M., H. Toumi, D. Suzuki, S. Redman, P. Emery, and D. McGonagle. 2007. Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum. 56: 224-233.
58. Mathieu, A., F. Paladini, A. Vacca, A. Cauli, M. T. Fiorillo, and R. Sorrentino. 2009. The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun. Rev. 8: 420-425.
59. Will, R., L. Edmunds, J. Elswood, and A. Calin. 1990. Is there sexual inequality in ankylosing spondylitis? A study of 498 women and 1202 men. J. Rheumatol. 17: 1649-1652.
60. Giltay, E. J., D. van Schaardenburg, L. J. Gooren, C. Popp-Snijders, and B. A. Dijkmans. 1999. Androgens and ankylosing spondylitis: a role in the pathogenesis? Ann. N. Y. Acad. Sci. 876: 340-364, discussion 365.
61. Lories, R. J., I. Derese, C. de Bari, and F. P. Luyten. 2007. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum. 56: 489-497.
62. van der Heijde, D., D. Salonen, B. N. Weissman, R. Landewé, W. P. Maksymowych, H. Kupper, S. Ballal, E. Gibson, and R. Wong, Canadian (M03-606) study group, ATLAS study group. 2009. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res. Ther. 11: R127.
63. Thomas, G. P., and M. A. Brown. 2010. Genetics and genomics of ankylosing spondylitis. Immunol. Rev. 233: 162-180.
64. Limón-Camacho, L., M. I. Vargas-Rojas, J. Vázquez-Mellado, J. Casasola-Vargas, J. F. Moctezuma, R. Burgos-Vargas, and L. Llorente. 2012. In vivo peripheral blood proinflammatory T cells in patients with ankylosing spondylitis. J. Rheumatol. 39: 830-835.
65. 1 male mice: a new mouse model. Mod. Rheumatol. 19: 316-322.